After the birth of her first child, an Illinois woman found herself caught in a slow unraveling — her body producing a hormone it could not stop, her fertility quietly extinguished by a benign tumor lodged at the base of her brain. In Chicago, a neurosurgeon named Dr. Stephen Magill removed the prolactinoma, and within a month, Lisa Fasone was pregnant again. Her story is a reminder that the body's disruptions sometimes have precise causes, and that persistence — in asking questions, in seeking answers, in refusing to accept silence — can be the difference between resignation and restoration.
Medical Xpress
· Jun 06, 2026
· health
· 2 min read
High
Sourcing: Verified
Brain surgery restores fertility for Illinois mom with pituitary tumor
Woman experienced prolonged infertility, hormonal dysfunction, and psychological distress from fear of never having another child, resolved through surgical intervention.
◉
General News
6456 related articles
Extreme Heat Triggers Unprecedented Early Harvest Across France's Wine…
The New York Times · 100% match
New York's Best Restaurants Right Now
The New York Times · 50% match
Dolly Parton's Quiet Power: A Lesson in Grace
The New York Times · 50% match
NYC Officials Narrow Second-Home Tax Scope, Extend Residency Deadline
The New York Times · 50% match
Gang Massacre in Haiti Kills Dozens, Escalating Capital Security Crisi…
The New York Times · 50% match
Related Coverage
NPR · Aug 26
Target Pulls Halloween Costume After Backlash Over Minstrel Show Imagery
Target removed a children's Halloween costume from shelves following social media outcry over design elements critics sa…
Al Jazeera · Aug 26 Fireworks factory destroyed in twin explosions in MexicoTwo explosions destroyed a fireworks facility in Tultepec, Mexico, flattening the building with spectacular flames and d…
PC Guide · Aug 26 Gigabyte QHD WOLED 280Hz gaming monitor hits 30-day low at $389.99A Gigabyte QHD WOLED 280Hz gaming monitor has dropped to $389.99 at Newegg, its lowest price in 30 days, offering premiu…
The Star · Aug 26 Gamescom opens with Final Fantasy, Witcher in focus amid industry turmoilEurope's largest gaming expo opens with Final Fantasy and The Witcher in focus, as the industry grapples with job cuts, …
Bias & Framing
⚖
Medical success story with minimal bias; straightforward reporting of patient case and surgical outcome with appropriate medical context and patient perspective.
Bias Direction
center
Confidence
HIGH
Human interest narrative combined with medical case study; frames surgery as solution to patient's fertility concerns through personal testimony and expert validation.
celebrating a growing family
feared she might never have another child
really not feeling like myself
face the issue
Potential risks or complications of pituitary surgery not discussed
Alternative treatment options beyond medication and surgery not explored
Long-term follow-up outcomes or success rates for similar procedures
Perspective from medical ethics regarding fertility-focused treatment decisions
Cost/accessibility considerations for specialized neurosurgery
Geopolitical Impact
🌎
This is a medical success story about individual healthcare, not a geopolitical event. No international implications exist.
Escalation Risk
N/A
Confidence
HIGH
Economic Lens
📈
Successful pituitary tumor removal restores fertility, demonstrating specialized neurosurgical advances with minimal direct economic impact but potential implications for healthcare specialization and fertility treatment markets.
Market Signal
neutral
Confidence
MED
Healthcare services - neurosurgery
Pharmaceutical - fertility and endocrine treatments
Medical devices - diagnostic imaging and surgical equipment
Fertility and reproductive medicine
Positive for patients seeking alternatives to long-term medication management; reduces lifetime pharmaceutical costs for affected individuals by eliminating need for prolactin-suppressing drugs; increases demand for specialized neurosurgical services and diagnostic imaging.
May influence insurance coverage decisions for surgical versus pharmaceutical treatment of prolactinomas; could support reimbursement for specialized neurosurgical procedures; potential for clinical guideline updates on treatment sequencing for hormone-producing pituitary tumors.